Feed URL: https://blogs.kent.ac.uk/bio-profiles/2013/08/28/dr-mark-howard/feed/?withoutcomments=1
Mark Howard joined the School of Biosciences as NMR Facility Manager in 2001 and has developed as an internationally respected researcher in Biological Nuclear Magnetic Resonance (NMR) Spectroscopy specialising in the uses of NMR to study metabolic pathway intermediates, peptides and proteins. Mark attended Aston University from 1988 to 2004 obtaining a BSc in Chemistry and a PhD in Physical Chemistry in the study of NMR and Ultrasound for novel method development in solid-state NMR spectroscopy. Following his PhD, Mark became a post-doctoral researcher at the University of Cambridge where we worked on NMR investigations of pyruvate dehydrogenase multi-enzyme complex in the laboratory of Prof Richard Perham FRS. Following this post, he became the Technical Officer of the 600 MHz NMR facility in Kent Biosciences from 1997-98. However, Mark was lured back to Cambridge to work under the directorship of Prof. Sir Alan Fersht FRS as manager of the NMR facility in the Medical Research Council Centre for Protein Engineering. In 2000, Mark pursued a brief 18 month excursion into industry, working for GE Healthcare on DNP Hypersense before returning to Kent in 2001 as NMR Facility Manager. From 2001 to present, Mark has risen through the ranks of Lecturer and Senior Lecturer to become Reader in Biological NMR Spectroscopy in 2011.
Mark’s research focus is centred on the continued development and application of NMR spectroscopy to biology, biotechnology and medicine. His interests circulate around the utilisation of NMR to study the identification, structure and dynamics of important biomolecules that relate to function, disease and therapies. A current particular interest is in the area of engineering new methods to inform on protein-ligand interactions for biochemical, pharmaceutical drug discovery and medical applications.
Mark is a member of the Protein Form and Function Group.
Mark Howard is a Chartered Chemist, Chartered Scientist and Member of the Royal Society of Chemistry (RSC). He has served from 2008-2013 as a member of the Advisory Board of the RSC Journal: Molecular Biosystems. He was also the executive chair of the BBSRC funded Collaborative Computing Project for NMR (CCPN) from 2010-2012. In addition, Mark holds Panel Memberships with both The Society of Biology and The Royal Society.